BlackRock (BLK)
NYSEFinancialsAsset ManagementSnapshot 2026-07-08
Reading BLK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BLK free→NYSEFinancialsAsset ManagementSnapshot 2026-07-08
Reading BLK? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track BLK free→QuarterlyIQ Insights · BLK
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 13 valuation methods, at three horizons. Current price $990.31. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 25% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $1,009 BLK trades at 20× p/e, in line with its 19× p/e peer median — but our blended $815 fair value sits below the price. We hold it with low confidence: our number sits well below the analyst range and quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Analysts target $1,140–$1,430. Note: our $815 fair value sits below the entire analyst range ($1,140–$1,430). Not investment advice.
$1140.00 – $1430.00 (median $1227.50) · 6 analysts · as of 2026-06-26
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Around its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $1227.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $202.35 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $182.69 | — | — | Hist. CAGR | high |
| ddm gordon | 12M | $115.51 | — | — | TTM | high |
| graham number | 12M | $618.45 | — | — | TTM | high |
| Peer P/B | 12M | $588.53 | 1.7 | 344.88 | TTM | high |
| Peer P/FCF | 12M | $295.82 | 13.7 | 21.60 | TTM | high |
| Peer P/E | 12M | $898.88 | 18.2 | 49.29 | TTM | high |
| Peer P/S | 12M | $462.81 | 3.0 | 155.38 | TTM | high |
| PEG | 12M | $851.73 | 17.3 | 49.29 | TTM | high |
| residual income | 12M | $407.09 | — | — | TTM | high |
| Own P/E history | 12M | $1098.43 | 22.3 | 49.29 | TTM | high |
| triangulated | 12M | $929.26 | 18.2 | 50.96 | Triangulated | high |
| Peer P/FCF | 3Y | $233.41 | 13.7 | 17.04 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $1367.08 | 18.2 | 74.96 | Analyst | medium |
| Peer P/S | 3Y | $711.93 | 3.0 | 239.02 | Analyst | medium |
| PEG | 3Y | $1295.37 | 17.3 | 74.96 | Analyst | medium |
| Own P/E history | 3Y | $1670.57 | 22.3 | 74.96 | Analyst | medium |
| Peer P/FCF | 5Y | $199.30 | 13.7 | 14.55 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $1807.97 | 18.2 | 99.14 | Analyst | high |
| Peer P/S | 5Y | $941.53 | 3.0 | 316.10 | Analyst | high |
| PEG | 5Y | $1713.13 | 17.3 | 99.14 | Analyst | high |
| Own P/E history | 5Y | $2209.34 | 22.3 | 99.14 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.